Brexpiprazole: so far so good | 合法藥品大搜索

本次. 將要介紹的新藥為Brexpiprazole（Rexulti®. ），即為第二代抗精神病藥，其藥理特性. 及臨床上之應用將在後續做討論。 表一2,3、治療思覺失調症藥物. 分類. Read More

於治療思覺失調症成人病人。 ▫ Brexpiprazole 治療的藥物計畫成本（drug plan cost）不應超. 過最低成本之非典型抗精神病製劑之藥物計畫成本。 PBAC（澳洲）. Read More

已知對brexpiprazole 或其任一成分過敏(包括皮疹、臉腫、蕁麻疹與過敏性反應(​anaphylaxis))的病人，禁用REXULTI。 注意事項, 1、針對失智症相關精神疾病之老年 ... Read More

Brexpiprazole, sold under the brand name Rexulti among others, is an atypical antipsychotic. It is a dopamine D2 receptor partial agonist and has been ... Read More

英文名稱. REXULTI® (brexpiprazole) tablets 2mg. 中文名稱. 銳思定®膜衣錠2毫克. 藥品分類. 06須由醫師處方使用. 主要成分. Brexpiprazole. 適應症. 思覺失調症。 Read More

由 LA Diefenderfer 著作 · 2017 · 被引用 19 次 — Brexpiprazole (Rexulti®, Otsuka Pharmaceutical Co, Ltd, Tokyo, Japan) is an atypical antipsychotic that was approved by the US Food and Drug ... Read More

由 S Das 著作 · 2016 · 被引用 44 次 — Brexpiprazole has antipsychotic-like activity and robust efficacy in relevant models of cognitive impairment associated with schizophrenia. It also has inhibitory ... Read More

Brexpiprazole is a N-arylpiperazine. ... Brexpiprazole is a novel D2 dopamine and serotonin 1A partial agonist, called serotonin-dopamine activity modulator (​SDAM) ... Read More

Medscape - Schizophrenia and depression dosing for brexpiprazole, frequency-​based adverse effects, comprehensive interactions, contraindications, ... Read More